Advertisement

European Radiology

, Volume 16, Issue 9, pp 1873–1886 | Cite as

Hepatocellular adenoma: findings at state-of-the-art magnetic resonance imaging, ultrasound, computed tomography and pathologic analysis

  • Shahid M. Hussain
  • Indra C. van den Bos
  • Roy S. Dwarkasing
  • Jan-Willem Kuiper
  • Jan den Hollander
Hepatobiliary-Pancreas

Abstract

The purpose of this paper is to describe the most recent concepts and pertinent findings of hepatocellular adenomas, including clinical presentation, gross pathology and histology, pathogenesis and transformation into hepatocellular carcinoma (HCC), and imaging findings at ultrasound (US), computed tomography (CT), and magnetic resonance (MR) imaging.

Keywords

Hepatocellular adenoma Pathology Ultrasound Computed tomography Magnetic resonance imaging 

References

  1. 1.
    Baum JK, Bookstein JJ, Holtz F, Klein EW (1973) Possible association between benign hepatomas and oral contraceptives. Lancet 2:926–929PubMedCrossRefGoogle Scholar
  2. 2.
    Edmondson H (1958) Tumors of the liver and intrahepatic bile ducts. In: FIo WDA (ed) Pathology. Atlas of tumor pathology. Washington, DCGoogle Scholar
  3. 3.
    Edmondson HA, Henderson B, Benton B (1976) Liver-cell adenomas associated with use of oral contraceptives. N Engl J Med 294:470–472PubMedCrossRefGoogle Scholar
  4. 4.
    Rooks JB, Ory HW, Ishak KG et al (1979) Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. JAMA 242:644–648PubMedCrossRefGoogle Scholar
  5. 5.
    Lindgren A, Olsson R (1993) Liver damage from low-dose oral contraceptives. J Intern Med 234:287–292PubMedCrossRefGoogle Scholar
  6. 6.
    Mamada Y, Onda M, Tajiri T et al (2001) Liver cell adenoma in a 26-year-old man. J Nippon Med Sch 68:516–519PubMedCrossRefGoogle Scholar
  7. 7.
    Psatha EA, Semelka RC, Armao D, Woosley JT, Firat Z, Schneider G (2005) Hepatocellular adenomas in men: MRI findings in four patients. J Magn Reson Imaging 22:258–264PubMedCrossRefGoogle Scholar
  8. 8.
    Terkivatan T, de Wilt JH, de Man RA et al (2001) Indications and long-term outcome of treatment for benign hepatic tumors: a critical appraisal. Arch Surg 136:1033–1038PubMedCrossRefGoogle Scholar
  9. 9.
    Terminology of nodular hepatocellular lesions (1995) International working party. Hepatology 22:983–993Google Scholar
  10. 10.
    Anthony P (2002) Tumours and tumour-like lesions of the liver and biliary tract: aetiology, epidemiology and pathology. In: MacSween RNM BA, Portmann BC (eds) Pathology of the liver. Churchill Livingstone, pp 711–775Google Scholar
  11. 11.
    Goodman ZD, Mikel UV, Lubbers PR, Ros PR, Langloss JM, Ishak KG (1987) Kupffer cells in hepatocellular adenomas. Am J Surg Pathol 11:191–196PubMedCrossRefGoogle Scholar
  12. 12.
    Prasad SR, Wang H, Rosas H et al (2005) Fat-containing lesions of the liver: radiologic–pathologic correlation. Radiographics 25:321–331PubMedCrossRefGoogle Scholar
  13. 13.
    Hussain SM, Semelka RC, Mitchell DG (2002) MR imaging of hepatocellular carcinoma. Magn Reson Imaging Clin N Am 10:31–52, vPubMedCrossRefGoogle Scholar
  14. 14.
    Lepreux S, Laurent C, Blanc JF et al (2003) The identification of small nodules in liver adenomatosis. J Hepatol 39:77–85PubMedCrossRefGoogle Scholar
  15. 15.
    Flejou JF, Barge J, Menu Y et al (1985) Liver adenomatosis. An entity distinct from liver adenoma? Gastroenterology 89:1132–1138PubMedGoogle Scholar
  16. 16.
    Paradis V, Benzekri A, Dargere D et al (2004) Telangiectatic focal nodular hyperplasia: a variant of hepatocellular adenoma. Gastroenterology 126:1323–1329PubMedCrossRefGoogle Scholar
  17. 17.
    Bioulac-Sage P, Rebouissou S, Sa Cunha A et al (2005) Clinical, morphologic, and molecular features defining so-called telangiectatic focal nodular hyperplasias of the liver. Gastroenterology 128:1211–1218PubMedCrossRefGoogle Scholar
  18. 18.
    Gordon SC, Reddy KR, Livingstone AS, Jeffers LJ, Schiff ER (1986) Resolution of a contraceptive-steroid-induced hepatic adenoma with subsequent evolution into hepatocellular carcinoma. Ann Intern Med 105:547–549PubMedGoogle Scholar
  19. 19.
    Gyorffy EJ, Bredfeldt JE, Black WC (1989) Transformation of hepatic cell adenoma to hepatocellular carcinoma due to oral contraceptive use. Ann Intern Med 110:489–490PubMedGoogle Scholar
  20. 20.
    Tao LC (1991) Oral contraceptive-associated liver cell adenoma and hepatocellular carcinoma. Cytomorphology and mechanism of malignant transformation. Cancer 68:341–347PubMedCrossRefGoogle Scholar
  21. 21.
    Ferrell LD (1993) Hepatocellular carcinoma arising in a focus of multilobular adenoma. A case report. Am J Surg Pathol 17:525–529PubMedCrossRefGoogle Scholar
  22. 22.
    Foster JH, Berman MM (1994) The malignant transformation of liver cell adenomas. Arch Surg 129:712–717PubMedGoogle Scholar
  23. 23.
    Hussain SM, Zondervan PE, JN IJ, Schalm SW, de Man RA, Krestin GP (2002) Benign versus malignant hepatic nodules: MR imaging findings with pathologic correlation. Radiographics 22:1023–1036, discussion 1037–1029PubMedGoogle Scholar
  24. 24.
    Welch TJ, Sheedy PF 2nd, Johnson CM et al (1985) Focal nodular hyperplasia and hepatic adenoma: comparison of angiography, CT, US, and scintigraphy. Radiology 156:593–595PubMedGoogle Scholar
  25. 25.
    Numata K, Tanaka K, Mitsui K, Morimoto M, Inoue S, Yonezawa H (1993) Flow characteristics of hepatic tumors at color Doppler sonography: correlation with arteriographic findings. AJR Am J Roentgenol 160:515–521PubMedGoogle Scholar
  26. 26.
    Bryant TH, Blomley MJ, Albrecht T et al (2004) Improved characterization of liver lesions with liver-phase uptake of liver-specific microbubbles: prospective multicenter study. Radiology 232:799–809PubMedCrossRefGoogle Scholar
  27. 27.
    Ichikawa T, Federle MP, Grazioli L, Nalesnik M (2000) Hepatocellular adenoma: multiphasic CT and histopathologic findings in 25 patients. Radiology 214:861–868PubMedGoogle Scholar
  28. 28.
    Grazioli L, Federle MP, Ichikawa T, Balzano E, Nalesnik M, Madariaga J (2000) Liver adenomatosis: clinical, histopathologic, and imaging findings in 15 patients. Radiology 216:395–402PubMedGoogle Scholar
  29. 29.
    Paulson EK, McClellan JS, Washington K, Spritzer CE, Meyers WC, Baker ME (1994) Hepatic adenoma: MR characteristics and correlation with pathologic findings. AJR Am J Roentgenol 163:113–116PubMedGoogle Scholar
  30. 30.
    Arrive L, Flejou JF, Vilgrain V et al (1994) Hepatic adenoma: MR findings in 51 pathologically proved lesions. Radiology 193:507–512PubMedGoogle Scholar
  31. 31.
    Chung KY, Mayo-Smith WW, Saini S, Rahmouni A, Golli M, Mathieu D (1995) Hepatocellular adenoma: MR imaging features with pathologic correlation. AJR Am J Roentgenol 165:303–308PubMedGoogle Scholar
  32. 32.
    Mathieu D, Bruneton JN, Drouillard J, Pointreau CC, Vasile N (1986) Hepatic adenomas and focal nodular hyperplasia: dynamic CT study. Radiology 160:53–58PubMedGoogle Scholar
  33. 33.
    Hussain SM, Semelka RC (2005) Hepatic imaging: comparison of modalities. Radiol Clin North Am 43:929–947, ixPubMedCrossRefGoogle Scholar
  34. 34.
    Hussain SM, Semelka RC (2005) Liver masses. Magn Reson Imaging Clin N Am 13:255–275PubMedCrossRefGoogle Scholar
  35. 35.
    Bartolozzi C, Lencioni R, Paolicchi A, Moretti M, Armillotta N, Pinto F (1997) Differentiation of hepatocellular adenoma and focal nodular hyperplasia of the liver: comparison of power Doppler imaging and conventional color Doppler sonography. Eur Radiol 7:1410–1415PubMedCrossRefGoogle Scholar
  36. 36.
    Bartolotta TV, Midiri M, Quaia E et al (2005) Benign focal liver lesions: spectrum of findings on SonoVue-enhanced pulse-inversion ultrasonography. Eur Radiol 15:1643–1649PubMedCrossRefGoogle Scholar
  37. 37.
    Klein D, Jenett M, Gassel HJ, Sandstede J, Hahn D (2004) Quantitative dynamic contrast-enhanced sonography of hepatic tumors. Eur Radiol 14:1082–1091PubMedCrossRefGoogle Scholar
  38. 38.
    Mahfouz AE, Hamm B, Taupitz M, Wolf KJ (1993) Hypervascular liver lesions: differentiation of focal nodular hyperplasia from malignant tumors with dynamic gadolinium-enhanced MR imaging. Radiology 186:133–138PubMedGoogle Scholar
  39. 39.
    McFarland EG, Mayo-Smith WW, Saini S, Hahn PF, Goldberg MA, Lee MJ (1994) Hepatic hemangiomas and malignant tumors: improved differentiation with heavily T2-weighted conventional spin-echo MR imaging. Radiology 193:43–47PubMedGoogle Scholar
  40. 40.
    Mitchell DG, Saini S, Weinreb J et al (1994) Hepatic metastases and cavernous hemangiomas: distinction with standard- and triple-dose gadoteridol-enhanced MR imaging. Radiology 193:49–57PubMedGoogle Scholar
  41. 41.
    Semelka RC, Martin DR, Balci C, Lance T (2001) Focal liver lesions: comparison of dual-phase CT and multisequence multiplanar MR imaging including dynamic gadolinium enhancement. J Magn Reson Imaging 13:397–401PubMedCrossRefGoogle Scholar
  42. 42.
    Hussain SM, Terkivatan T, Zondervan PE et al (2004) Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT, and pathologic analysis. Radiographics 24:3–17, discussion 18–19PubMedCrossRefGoogle Scholar
  43. 43.
    Attal P, Vilgrain V, Brancatelli G et al (2003) Telangiectatic focal nodular hyperplasia: US, CT, and MR imaging findings with histopathologic correlation in 13 cases. Radiology 228:465–472PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • Shahid M. Hussain
    • 1
    • 3
  • Indra C. van den Bos
    • 1
  • Roy S. Dwarkasing
    • 1
  • Jan-Willem Kuiper
    • 1
  • Jan den Hollander
    • 2
  1. 1.Department of RadiologyErasmus Medical CenterRotterdamThe Netherlands
  2. 2.Department of PathologyErasmus Medical CenterRotterdamThe Netherlands
  3. 3.Department of RadiologyUniversity of Nebraska Medical CenterOmahaUSA

Personalised recommendations